Ligand-regulated Internalization, Trafficking, and Down-regulation of Guanylyl Cyclase/Atrial Natriuretic Peptide Receptor-A in Human Embryonic Kidney 293 Cells

• Published in: The Journal of biological chemistry Vol. 277; no. 7; pp. 4618 - 4627
• Main Authors: Pandey, Kailash N, Nguyen, Huong T, Sharma, Guru Dutt, Shi, Shang-Jin, Kriegel, Alison M
• Format: Journal Article
• Language: English
• Published: United States American Society for Biochemistry and Molecular Biology 15.02.2002
• Subjects: Animals; Binding, Competitive; Cell Line; Dose-Response Relationship, Drug; Down-Regulation; Guanylate Cyclase - chemistry; Guanylate Cyclase - metabolism; Humans; Kinetics; Ligands; Models, Biological; Plasmids - metabolism; Protein Binding; Protein Transport; Rats; Receptors, Atrial Natriuretic Factor - chemistry; Receptors, Atrial Natriuretic Factor - metabolism; Recombinant Proteins - metabolism; Temperature; Time Factors; Transfection
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.M106436200

We examined the kinetics of internalization, trafficking, and down-regulation of recombinant guanylyl cyclase/natriuretic peptide receptor-A (NPRA) utilizing stably transfected 293 cells expressing a very high density of receptors. After atrial natriuretic peptide (ANP) binding to NPRA, ligand-receptor complexes are internalized, processed intracellularly, and sequestered into subcellular compartments, which provided an approach to examining directly the dynamics of metabolic turnover of NPRA in intact cells. The translocation of ligand-receptor complexes from cell surface to intracellular compartments seems to be linked to ANP-dependent down-regulation of NPRA. Using tryptic proteolysis of cell surface receptors, it was found that ∼40–50% of internalized ligand-receptor complexes recycled back to the plasma membrane with an apparent t = 8 min. The recycling of NPRA was blocked by the lysosomotropic agent chloroquine, the energy depleter dinitrophenol, and also by low temperature, suggesting that recycling of the receptor is an energy- and temperature-dependent process. Data suggest that ∼70–80% of internalized 125 I-ANP is processed through a lysosomal degradative pathway; however, 20–25% of internalized ligand is released intact into the cell exterior through an alternative mechanism involving an chloroquine-insensitive pathway. It is implied that internalization and processing of bound ANP-NPRA complexes may play an important role in mediating the biological action of hormone and the receptor protein. In retrospect, this could occur at the level of receptor regulation or through the initiation of ANP mediated signals. It is envisioned that the endocytotic pathway of ligand-receptor complexes of ANP-NPRA would lead to termination and/or diminished responsiveness of ANP in target cells.